WHO warns against Indian-made cough remedies as 66 children die in Gambia


The World Health Organization has issued a warning that four cough and cold syrups produced by Maiden Pharmaceuticals in India could be linked to the deaths of 66 children in Gambia. The UN health agency says contaminated medication may have been distributed to other countries.

WHO chief Tedros Adhanom Ghebreyesus told reporters the four cold and cough syrups in question "have been potentially linked with acute kidney injuries and 66 deaths among children".

"The loss of these young lives is beyond heartbreaking for their families."

Tedros said the UN agency was also "conducting further investigation with the company and regulatory authorities in India".

According to the medical product alert issued by WHO Wednesday, the four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

The WHO said information received from India's Central Drugs Standard Control Organisation indicated that the manufacturer had supplied the contaminated medication only to The Gambia.

Tedros, however, has warned that wider distribution could not be ruled out. The WHO chief has called for caution at the global level.

Spate of kidney disease in children

On Thursday, Gambian authorities began collecting paracetamol and promethazine syrup from rural households in the West Coast Region and Upper River Region.

"The preliminary results from the ongoing investigation indicate that it is most probably the paracetamol and promethazine syrups that caused the acute kidney injury cases in this outbreak," Abubacarr Jagne, the nephrologist leading the health ministry's investigation, told the French AFP news agency.

Read more on RFI

Read also:
S2,EP20: Nigeria's 3D print revolution, Gambia combats kidney disease & Kenya's elephant issues
Gambian musician Sana Singhateh launches 'one million trees' planting initiative
Gambian court sentences five former spies to death for Jammeh-era murder